Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibitionHongyu Ding, Thales Papagiannakopoulos, Zihong Chen et al.|Science Advances|2021Cited by 91
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancerRay Pillai, Thales Papagiannakopoulos|Science Advances|2024Cited by 57
Targeting FSP1 triggers ferroptosis in lung cancerKatherine Wu, Thales Papagiannakopoulos, Alec Vaughan et al.|Nature|2025Cited by 47
Targeting FSP1 triggers ferroptosis in lung cancerKatherine Wu, Thales Papagiannakopoulos, Alec Vaughan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 2